New hope for tough leukemia: experimental drug BL-M11D1 enters human testing
NCT ID NCT06714591
First seen Oct 31, 2025 · Last updated Jun 16, 2026 · Updated 34 times
Summary
This early-stage study tests a new drug called BL-M11D1 in 120 adults whose acute myeloid leukemia has returned or not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it helps control the disease. Participants must have a specific marker (CD33) on their leukemia cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
City of Hope
RECRUITINGDuarte, California, 91010, United States
Contact
Contact Email: •••••@•••••
-
Fred Hutchinson Cancer Center
RECRUITINGSeattle, Washington, 98109, United States
Contact
Contact Email: •••••@•••••
-
John Theurer Cancer Center-Hackensack
RECRUITINGHackensack, New Jersey, 07601, United States
Contact
Contact Email: •••••@•••••
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact
Contact Email: •••••@•••••
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact
Contact Email: •••••@•••••
-
Northwestern Memorial Hospital
RECRUITINGChicago, Illinois, 60611, United States
Contact
Contact Email: •••••@•••••
-
Oncology Hematology Care Clinical Trials, LLC
RECRUITINGCincinnati, Ohio, 45236, United States
Contact Email: •••••@•••••
Contact
-
Oregon Health and Science University
RECRUITINGPortland, Oregon, 97239, United States
Contact Email: •••••@•••••
Contact
-
SCRI -TriStar BMT
RECRUITINGNashville, Tennessee, 37203, United States
Contact Email: •••••@•••••
Contact
-
START Midwest/The Cancer and Hematology Center
RECRUITINGGrand Rapids, Michigan, 49546, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Temple Health Fox Chase Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19111, United States
Contact Email: •••••@•••••
Contact
-
The Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
Contact Email: •••••@•••••
Contact
-
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
RECRUITINGBaltimore, Maryland, 21287, United States
Contact
Contact Email: •••••@•••••
-
UCLA Ronald Reagan Medical Center
RECRUITINGLos Angeles, California, 90095, United States
Contact Email: •••••@•••••
Contact
-
University of Colorado Anschutz Medical Campus
RECRUITINGAurora, Colorado, 80045, United States
Contact
Contact Email: •••••@•••••
-
Virginia Cancer Specialists
RECRUITINGFairfax, Virginia, 22031, United States
Contact Email: •••••@•••••
Contact
-
WVCI Oncology Associates of Oregon
RECRUITINGEugene, Oregon, 24224, United States
Contact Email: •••••@•••••
Contact
-
Yale Cancer Center, Smilow Cancer Hospital at Yale New Haven
RECRUITINGNew Haven, Connecticut, 06511, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.